Decitabine
Decitabine is an intravenous prescription drug used to treat certain blood disorders like myelodysplastic syndromes and acute myeloid leukemia. It comes as a lyophilized powder in 50 mg vials, manufactured by Ingenus Pharmaceuticals, LLC. As a nucleoside metabolic inhibitor, it works by interfering with DNA synthesis in cancer cells. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Decitabine is an intravenous prescription drug used to treat certain blood disorders like myelodysplastic syndromes and acute myeloid leukemia. It comes as a lyophilized powder in 50 mg vials, manufactured by Ingenus Pharmaceuticals, LLC. As a nucleoside metabolic inhibitor, it works by interfering with DNA synthesis in cancer cells. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Decitabine",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Decitabine — ANDA 205539 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205539"
}
]
|
| identifier | ANDA205539 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"fda",
"medications",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Decitabine |
